LX-6171

LX-6171 is an orally active SLC6A7 inhibitor. LX-6171 can be used to study diseases characterized by cognitive impairment, such as Alzheimer's disease, schizophrenia or vascular dementia[1].

Product Specifications

CAS Number

[914808-66-5]

UNSPSC

12352005

Target

Amino acid Transporter

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/lx-6171.html

Solubility

10 mM in DMSO

Smiles

O=C(C1CCN(CC1)C2=NC=CC=N2)C3=CC=C(C=C3)C4=CC=CC(Cl)=C4

Molecular Formula

C22H20ClN3O

Molecular Weight

377.87

References & Citations

[1]

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

Phase 2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MBS6301973-01 0.2 mL

GFPT2, ID (GFPT2, Glucosamine-fructose-6-phosphate aminotransferase [isomerizing] 2, D-fructose-6-phosphate amidotransferase 2, Glutamine:fructose 6 phosphate amidotransferase 2, Hexosephosphate aminotransferase 2) (AP)

Ask

View Details

MBS6301973-02 5x 0.2 mL

GFPT2, ID (GFPT2, Glucosamine-fructose-6-phosphate aminotransferase [isomerizing] 2, D-fructose-6-phosphate amidotransferase 2, Glutamine:fructose 6 phosphate amidotransferase 2, Hexosephosphate aminotransferase 2) (AP)

Ask

View Details

DF14880-01 100 µL

SMR3A Antibody

Ask

View Details

DF14880-02 200 µL

SMR3A Antibody

Ask

View Details